Design and activity of a 'dual-targeted' antimicrobial peptide

International Journal of Antimicrobial Agents

Volumn 33, Issue 6, 2009, Pages 532-537

  He, Jian ^a   Anderson, Maxwell H ^b   Shi, Wenyuan ^a   Eckert, Randal ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b C3 Jian Inc   (United States)

Author keywords

Antimicrobial peptide; MH STAMP; Novel antibiotic; Peptide synthesis; Pseudomonas aeruginosa; Specifically targeted antimicrobial peptide; STAMP; Streptococcus mutans; Targeted therapeutic

Indexed keywords

ANTIINFECTIVE AGENT; MULTIPLE HEADED SPECIFICALLY TARGETED ANTIMICROBIAL PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; SPECTINOMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM; BACTERIUM CULTURE; DRUG ACTIVITY; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULE; NONHUMAN; ORGANISM; PEPTIDE SYNTHESIS; PLANKTON; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPECTROSCOPY; STREPTOCOCCUS MUTANS;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS MUTANS;

EID: 64549112594     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.11.013     Document Type: Article

References (34)

1. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3 (2003) 710-720
2. Hancock R.E., and Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol 16 (1998) 82-88
3. Genco C.A., Maloy W.L., Kari U.P., and Motley M. Antimicrobial activity of magainin analogues against anaerobic oral pathogens. Int J Antimicrob Agents 21 (2003) 75-78
4. He J., Eckert R., Pharm T., Simanian M.D., Hu C., Yarbrough D.K., et al. Novel synthetic antimicrobial peptides against Streptococcus mutans. Antimicrob Agents Chemother 51 (2007) 1351-1358
5. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 3 (2005) 238-250
6. Muhle S.A., and Tam J.P. Design of Gram-negative selective antimicrobial peptides. Biochemistry 40 (2001) 5777-5785
7. Tossi A., Sandri L., and Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55 (2000) 4-30
8. Tam J.P., Lu Y.A., and Yang Y.L. Antimicrobial dendrimeric peptides. Eur J Biochem 269 (2002) 923-932
9. Pini A., Giuliani A., Falciani C., Runci Y., Ricci C., Lelli B., et al. Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother 49 (2005) 2665-2672
10. Eckert R., He J., Yarbrough D.K., Qi F., Anderson M.H., and Shi W. Targeted killing of Streptococcus mutans by a pheromone-guided 'smart' antimicrobial peptide. Antimicrob Agents Chemother 50 (2006) 3651-3657
11. Eckert R., Qi F., Yarbrough D.K., He J., Anderson M.H., and Shi W. Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrob Agents Chemother 50 (2006) 1480-1488
12. Drake J.W., Charlesworth B., Charlesworth D., and Crow J.F. Rates of spontaneous mutation. Genetics 148 (1998) 1667-1686
13. Eckert R., Brady K.M., Greenberg E.P., Qi F., Yarbrough D.K., He J., et al. Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother 50 (2006) 3833-3838
14. Sprenger G.A., and Lengeler J.W. l-Sorbose metabolism in Klebsiella pneumoniae and Sor+ derivatives of Escherichia coli K-12 and chemotaxis toward sorbose. J Bacteriol 157 (1984) 39-45
15. Podbielski A., Spellerberg B., Woischnik M., Pohl B., and Lütticken R. Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene 177 (1996) 137-147
16. Duthie E.S., and Lorenz L.L. Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 6 (1952) 95-107
17. Merritt J., Kreth J., Qi F., Sullivan R., and Shi W. Non-disruptive, real-time analyses of the metabolic status and viability of Streptococcus mutans cells in response to antimicrobial treatments. J Microbiol Methods 61 (2005) 161-170
18. Anderson R.C., Rehders M., and Yu P.L. Antimicrobial fragments of the pro-region of cathelicidins and other immune peptides. Biotechnol Lett 30 (2008) 813-818
19. Aas J.A., Paster B.J., Stokes L.N., Olsen I., and Dewhirst F.E. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43 (2005) 5721-5732
20. Boman H.G. Innate immunity and the normal microflora. Immunol Rev 173 (2000) 5-16
21. Kreth J., Merritt J., Shi W., and Qi F. Competition and coexistence between Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J Bacteriol 187 (2005) 7193-7203
22. Metges C.C. Contribution of microbial amino acids to amino acid homeostasis of the host. J Nutr 130 (2000) 1857S-1864S
23. Sears C.L. A dynamic partnership: celebrating our gut flora. Anaerobe 11 (2005) 247-251
24. Lievin-Le Moal V., and Servin A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 19 (2006) 315-337
25. DiBaise J.K., Zhang H., Crowell M.D., Krajmalnik-Brown R., Deckert G.A., and Rittmann B.E. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 83 (2008) 460-469
26. Loesche W.J. Role of Streptococcus mutans in human dental decay. Microbiol Rev 50 (1986) 353-380
27. Gould C.V., and McDonald L.C. Bench-to-bedside review: Clostridium difficile colitis. Crit Care 12 (2008) 203
28. Leyden J.J., McGinley K.J., Holzle E., Labows J.N., and Kligman A.M. The microbiology of the human axilla and its relationship to axillary odor. J Invest Dermatol 77 (1981) 413-416
29. Elsner P. Antimicrobials and the skin physiological and pathological flora. Curr Probl Dermatol 33 (2006) 35-41
30. Govan J.R., and Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60 (1996) 539-574
31. Paster B.J., Boches S.K., Galvin J.L., Ericson R.E., Lau C.N., Levanos V.A., et al. Bacterial diversity in human subgingival plaque. J Bacteriol 183 (2001) 3770-3783
32. Schlessinger D. Failure of aminoglycoside antibiotics to kill anaerobic, low-pH, and resistant cultures. Clin Microbiol Rev 1 (1988) 54-59
33. Tresse O., Jouenne T., and Junter G. Antibacterial efficacy of tobramycin against anaerobic Escherichia coli cultures in the presence of electron acceptors. J Antimicrob Chemother 40 (1997) 419-421
34. Keene H.J., and Shklair I.L. Relationship of Streptococcus mutans carrier status to the development of carious lesions in initially cariesfree recruits. J Dent Res 53 (1974) 1295